Skip to main content

Medicare & Medicaid

By Mallory Hackett | 05:28 pm | November 24, 2020
Risk adjustment data validation ensures payment integrity and accuracy – and it affects what plans are paid.
By Susan Morse | 03:44 pm | November 24, 2020
Barring an appeals court decision overturning the rule, the mandate goes into effect on January 1, 2021.
By Susan Morse | 11:54 am | November 24, 2020
PhRMA questions the cost savings and says the rule leaves safety considerations to state governments, rather than the required federal oversight.
By Mallory Hackett | 05:43 pm | November 23, 2020
The treatment will be available at no cost to patients, although healthcare facilities may charge for the administration.
By Susan Morse | 11:58 am | November 23, 2020
The interim rule would cut drug reimbursements to hospitals by an average of 65% when fully phased in, the AHA says.
By Susan Morse | 02:02 pm | November 21, 2020
The old federal regulations burdened providers with added administrative costs and fear of financial consequences, CMS says.
By Susan Morse | 01:27 pm | November 21, 2020
Opponents say the rule will not lower drug prices, and some question whether it is legal, having bypassed the public comment process.
By Mallory Hackett | 03:26 pm | November 20, 2020
The letter warns that the new thresholds are too high and will force many clinicians to exit from APMs and revert back to fee-for-service.
By Jeff Lagasse | 05:14 pm | November 19, 2020
Medicare negotiation could result in 94,000 fewer deaths annually, and reduce spending by $475.9 billion by 2030.
By Susan Morse | 10:18 am | November 19, 2020
The allegations were brought by a whistleblower former employee who will receive about $1.5 million as her share of the recovery.